Mechanistic exploration of Yiqi Liangxue Shengji prescription on restenosis after balloon injury by integrating metabolomics with network pharmacology

CONTEXT: Yiqi Liangxue Shengji prescription (YQLXSJ) is a traditional Chinese medicine (TCM) formula that has long been used for treatment after percutaneous coronary intervention (PCI). OBJECTIVE: To investigate the putative pharmacological mechanism of YQLXSJ on restenosis through an integrated ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Tianshi, Xie, Long, Guo, Yanqiong, Ji, Xiang, Wan, Jie, Cui, Xiaoyun, Fan, Qian, Liu, Wei, Wang, Shuai, Han, Wenbo, Lin, Qian, Jia, Wenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443980/
https://www.ncbi.nlm.nih.gov/pubmed/37602438
http://dx.doi.org/10.1080/13880209.2023.2244533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443980/
https://www.ncbi.nlm.nih.gov/pubmed/37602438
http://dx.doi.org/10.1080/13880209.2023.2244533

Ejemplares similares